Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33844469

Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2021 Aug
First author
Levy AS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Levy AS
      type
      Author
    2. name
      Krailo M
      type
      Author
    3. name
      Chi S
      type
      Author
    4. name
      Villaluna D
      type
      Author
    5. name
      Springer L
      type
      Author
    6. name
      Williams-Hughes C
      type
      Author
    7. name
      Fouladi M
      type
      Author
    8. name
      Gajjar A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Levy AS
      type
      Author
    2. name
      Krailo M
      type
      Author
    3. name
      Chi S
      type
      Author
    4. name
      Villaluna D
      type
      Author
    5. name
      Springer L
      type
      Author
    6. name
      Williams-Hughes C
      type
      Author
    7. name
      Fouladi M
      type
      Author
    8. name
      Gajjar A
      type
      Author
    bibliography ids
    1. nci-bib-0b96c28f5928c9f5478c6fff
    book metadata
    content sha256
    c273d85d4d20f065011034c02ffb953db5d15b3460f338b77c5944a8f7f5b342
    document type
    citation
    dois
    1. 10.1002/pbc.29031
    electronic publication date
    display
    2021 Apr 12
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33844469
    immutable id
    pubmed:33844469@c273d85d4d20f065011034c02ffb953db5d15b3460f338b77c5944a8f7f5b342
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    8
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e29031
    volume
    68
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33844469
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      c7404ad2c45d31ff59cbcbb4516613ba9e11f3143421d320f6b898d9d8958238
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Aug
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33844469/
      title
      Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial.

      Preserved source evidence · Not medical advice